Vanderbilt University Medical Center
Nashville, Tennessee, 37232, United States
NCT Number: NCT06688734
The goal of this clinical trial is to compare the effect of placing chest tubes to water seal versus suction initially, in patients with traumatic pneumothoraces, on overall chest tube duration.
The main question it aims to answer is:
* Does placing chest tubes to water seal initially results in a shorter chest tube duration, without an increase in complications?
Alternating each month, patients' chest tubes will either be placed to water seal or to suction initially. All other management decisions related to the chest tube will be left to the providers.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Nashville, Tennessee, 37232, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
After chest tube placement, the chest tube will be placed to 20cm H2O of suction for 1 minute to evacuate all pneumothorax. After this, the chest tube will be placed to water seal, defined as the water seal chamber on the chest tube drainage system being filled up to the 2cm line and not on suction. All other management decisions related to the chest tube will be left to the providers.
After chest tube placement, the suction group will have their chest tube placed to 20cm H2O of suction delivered by the chest tube drainage suction. All other management decisions related to the chest tube will be left to the providers.
Time frame: Through study completion, an average of 1 year
Duration of the initial chest tube, measured in hours
Time frame: Through study completion, an average of 1 year
Yes/No
Time frame: Through study completion, an average of 1 year
Yes/no
Time frame: Through study completion, an average of 1 year
Yes/no Yes if growth of pneumothorax on chest x-ray with tube to water seal
Time frame: Through study completion, an average of 1 year
Yes/no Yes if chest tube removed and then a new one is place on the same side at a later time
Time frame: Through study completion, an average of 1 year
Yes/no Yes if pneumothorax grows on chest x-ray after chest tube removal
Time frame: Through study completion, an average of 1 year
Yes/no Yes if <90% O2 saturation is recorded in chart
Time frame: Through study completion, an average of 1 year
Yes/no Yes if clinically diagnosed by provider based off of imaging, operative findings, clinical picture, culture results, or operative findings
Time frame: Through study completion, an average of 1 year
Yes/no Yes if clinically diagnosed and treated for pneumonia
Time frame: Through study completion, an average of 1 year
Yes/no Yes if >300cc hemothorax seen on CT scan after chest tube placement
Time frame: Through study completion, an average of 1 year
Yes/no Yes if any TPA administered to the affected side of the chest
Time frame: Through study completion, an average of 1 year
Yes/no Yes if skin and soft tissue infection treated with incision and drainage, or antibiotics
Time frame: Through study completion, an average of 1 year
Yes/no Yes if receives video-assisted thoracoscopic surgery on the affected side during initial admission
Time frame: Through study completion, an average of 1 year
Yes/no Yes if intubated for hypoxia or hypercapnea during hospital stay
Time frame: Through study completion, an average of 1 year
Yes/no Yes if admitted to ICU unexpectedly, for clinical deterioration
Time frame: Through study completion, an average of 1 year
Yes/no Yes if died within 30 days of initial presentation
Time frame: Through study completion, an average of 1 year
Integer, measured in days, length of initial hospital stay
Time frame: Through study completion, an average of 1 year
Yes/no Yes if readmitted within 30 days of discharge
Time frame: Through study completion, an average of 1 year
Yes/no Yes if readmitted and receives chest tube, video-assisted thoracoscopic surgery, or thoracotomy on the affected side
Time frame: Through study completion, an average of 1 year
Measured in cm, largest distance from lung edges to chest wall
Time frame: Through study completion, an average of 1 year
Yes/no Recorded each day there is a chest tube present
Time frame: Through study completion, an average of 1 year
Integer, number of chest x-rays after initial trauma evaluation
Time frame: Through study completion, an average of 1 year
Integer value Number of CT scans of chest after initial trauma evaluation during hospital stay
Time frame: Through study completion, an average of 1 year
Integer, dollar amount Total cost of chest tube supplies utilized, imaging (chest x-rays plus CT scans of chest), operative room costs if applicable, hospital days
Time frame: Through study completion, an average of 1 year
Yes/no Yes if was on mechanical ventilation at any point during hospitalization
Time frame: Through study completion, an average of 1 year
Total times spent in the ICU, measured in days
Time frame: Through study completion, an average of 1 year
Categorical Home, inpatient rehab, skilled nursing facility, long term acute care hospital, or died
Vanderbilt University Medical Center
Other
Acronym: SEAL IT
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00575198
Pleural Diseases, Pleural Effusion
Sacramento, California, United States
View Trial DetailsNCT01670942
Pleural Diseases, Pneumothorax
Murray, Utah, United States
View Trial DetailsNCT05963945
Atelectasis, Cardiomegaly
Havířov, Czechia
View Trial DetailsNCT03098524
Atelectasis, Bleeding
Neuilly-sur-Seine, Île-de-France Region, France
View Trial Details